These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 33841399)

  • 1. A Phase II Randomized Clinical Trial and Mechanistic Studies Using Improved Probiotics to Prevent Oral Mucositis Induced by Concurrent Radiotherapy and Chemotherapy in Nasopharyngeal Carcinoma.
    Xia C; Jiang C; Li W; Wei J; Hong H; Li J; Feng L; Wei H; Xin H; Chen T
    Front Immunol; 2021; 12():618150. PubMed ID: 33841399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma.
    Jiang C; Wang H; Xia C; Dong Q; Chen E; Qiu Y; Su Y; Xie H; Zeng L; Kuang J; Ao F; Gong X; Li J; Chen T
    Cancer; 2019 Apr; 125(7):1081-1090. PubMed ID: 30521105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: A multicenter, open-label, randomized controlled trial.
    Liang L; Liu Z; Zhu H; Wang H; Wei Y; Ning X; Shi Z; Jiang L; Lin Z; Yan H; Wang R; Hu K
    Cancer; 2022 Apr; 128(7):1467-1474. PubMed ID: 34910297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivariable model for predicting acute oral mucositis during combined IMRT and chemotherapy for locally advanced nasopharyngeal cancer patients.
    Orlandi E; Iacovelli NA; Rancati T; Cicchetti A; Bossi P; Pignoli E; Bergamini C; Licitra L; Fallai C; Valdagni R; Cavallo A
    Oral Oncol; 2018 Nov; 86():266-272. PubMed ID: 30409311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raltitrexed versus 5-fluorouracil with cisplatin and concurrent radiotherapy for locally advanced nasopharyngeal carcinoma: An open labeled, randomized, controlled, and multicenter clinical trial.
    Yan P; Yin H; Guo W; Sun X; Li F; Huang S; Bian X; Wang F; Zhang F; Wang B; Zhou H; Zhou C; Yin L; Jiang X; Jiang N; Wu J; Liu J; Song D; He X
    Cancer Med; 2020 Sep; 9(17):6166-6172. PubMed ID: 32657029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of probiotics in prevention and treatment of cancer therapy-induced oral mucositis: A systematic review and meta-analysis.
    Shu Z; Li P; Yu B; Huang S; Chen Y
    Oral Oncol; 2020 Mar; 102():104559. PubMed ID: 31923856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, Double-Blind, Placebo-Controlled Trial of Shuanghua Baihe Tablets to Prevent Oral Mucositis in Patients With Nasopharyngeal Cancer Undergoing Chemoradiation Therapy.
    Zheng B; Zhu X; Liu M; Yang Z; Yang L; Lang J; Shi M; Wu G; He X; Chen X; Xi X; Zhao D; Zhu G
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):418-426. PubMed ID: 29353657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
    Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
    Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of immunonutrition in patients with head and neck cancer receiving chemoradiation: A phase II randomized, double-blind study.
    Dechaphunkul T; Arundon T; Raungkhajon P; Jiratrachu R; Geater SL; Dechaphunkul A
    Clin Nutr; 2022 Feb; 41(2):433-440. PubMed ID: 35007812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the NCI-CTCAE version 4.0 and version 3.0 in assessing chemoradiation-induced oral mucositis for locally advanced nasopharyngeal carcinoma.
    Liu YJ; Zhu GP; Guan XY
    Oral Oncol; 2012 Jun; 48(6):554-9. PubMed ID: 22289637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
    Legouté F; Bensadoun RJ; Seegers V; Pointreau Y; Caron D; Lang P; Prévost A; Martin L; Schick U; Morvant B; Capitain O; Calais G; Jadaud E
    Radiat Oncol; 2019 May; 14(1):83. PubMed ID: 31118057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study.
    Hong RL; Hsiao CF; Ting LL; Ko JY; Wang CW; Chang JTC; Lou PJ; Wang HM; Tsai MH; Lai SC; Liu TW
    Ann Oncol; 2018 Sep; 29(9):1972-1979. PubMed ID: 30016391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer.
    Anderson CM; Lee CM; Saunders DP; Curtis A; Dunlap N; Nangia C; Lee AS; Gordon SM; Kovoor P; Arevalo-Araujo R; Bar-Ad V; Peddada A; Colvett K; Miller D; Jain AK; Wheeler J; Blakaj D; Bonomi M; Agarwala SS; Garg M; Worden F; Holmlund J; Brill JM; Downs M; Sonis ST; Katz S; Buatti JM
    J Clin Oncol; 2019 Dec; 37(34):3256-3265. PubMed ID: 31618127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy.
    Sunaga T; Nagatani A; Fujii N; Hashimoto T; Watanabe T; Sasaki T
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1317. PubMed ID: 33295153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy.
    Yokota T; Tachibana H; Konishi T; Yurikusa T; Hamauchi S; Sakai K; Nishikawa M; Suzuki M; Naganawa Y; Hagihara T; Tsumaki H; Kubo T; Sato M; Taguri M; Morita S; Eguchi T; Kubota K; Zenda S
    Support Care Cancer; 2016 Jul; 24(7):3029-36. PubMed ID: 26887378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial.
    Cao SM; Yang Q; Guo L; Mai HQ; Mo HY; Cao KJ; Qian CN; Zhao C; Xiang YQ; Zhang XP; Lin ZX; Li WX; Liu Q; Qiu F; Sun R; Chen QY; Huang PY; Luo DH; Hua YJ; Wu YS; Lv X; Wang L; Xia WX; Tang LQ; Ye YF; Chen MY; Guo X; Hong MH
    Eur J Cancer; 2017 Apr; 75():14-23. PubMed ID: 28214653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulations of probiotics on gut microbiota in a 5-fluorouracil-induced mouse model of mucositis.
    Yeung CY; Chiang Chiau JS; Cheng ML; Chan WT; Chang SW; Chang YH; Jiang CB; Lee HC
    J Gastroenterol Hepatol; 2020 May; 35(5):806-814. PubMed ID: 31674687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waldeyer ring microbiome in relation to chemoradiation-induced oral mucositis in patients with nasopharyngeal carcinoma.
    Chung A; Chung YT; Liang YW; Chung YL
    Head Neck; 2023 Aug; 45(8):2047-2057. PubMed ID: 37337976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of controlled-release oxycodone for reducing pain due to oral mucositis in nasopharyngeal carcinoma patients treated with concurrent chemoradiotherapy: a prospective clinical trial.
    Hua X; Chen LM; Zhu Q; Hu W; Lin C; Long ZQ; Wen W; Sun XQ; Lu ZJ; Chen QY; Luo DH; Sun R; Mo HY; Tang LQ; Zhang WW; He ZY; Mai HQ; Lin HX; Guo L
    Support Care Cancer; 2019 Oct; 27(10):3759-3767. PubMed ID: 30712098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, controlled phase II trial of maxillofacial and oral massage in attenuating severe radiotherapy-induced oral mucositis and lipid metabolite changes in nasopharyngeal carcinoma.
    Yang G; Feng D; Li F; Luo B; Zhu J; Yang Q; Zheng L; Dong Q; Chen M; Xu Z; Li L; Chen P; Sun J
    Radiother Oncol; 2021 Oct; 163():76-82. PubMed ID: 34343545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.